Core Viewpoint - Southbound funds have reduced their holdings in China People's Insurance Group (01339.HK) by 3.08 million shares on February 5, with a total net reduction of 15.3 million shares over the last five trading days and 30.44 million shares over the last 20 trading days [1] Group 1: Shareholding Changes - Southbound funds have reduced their holdings in China People's Insurance Group for 4 out of the last 5 trading days, totaling a net reduction of 15.3 million shares [1] - Over the last 20 trading days, there have been 15 days of reductions, with a cumulative net reduction of 30.44 million shares [1] - As of now, southbound funds hold 2.522 billion shares of China People's Insurance Group, representing 28.89% of the company's total issued ordinary shares [1] Group 2: Company Overview - China People's Insurance Group is a holding company primarily engaged in providing insurance products [1] - The company and its subsidiaries are involved in various insurance sectors, including property insurance, health insurance, life insurance, reinsurance, Hong Kong insurance, and pension insurance [1] - The property insurance segment includes products for both corporate and individual clients, such as motor vehicle insurance, agricultural insurance, property insurance, and liability insurance [1] - The health insurance segment focuses on health and medical insurance products [1] - The life insurance segment offers various life insurance products, including participating, whole life, annuity, and universal life insurance [1] - The Hong Kong insurance segment covers property insurance business in Hong Kong [1] - The pension insurance segment includes corporate annuities and occupational annuities [1]

Group 1 - China People's Insurance Group (China P&C) is committed to enhancing service efficiency through technological innovation, focusing on the development of an intelligent Q&A system for medical insurance knowledge to meet the growing demand for medical insurance inquiries [1][2] - The project aims to build a high-efficiency and precise medical insurance knowledge intelligent Q&A system, with a tender announcement published on January 4, 2026, attracting several well-known technology companies to participate [1] - The procurement focuses on system development and knowledge base construction, utilizing intelligent Q&A technology to help China P&C quickly respond to medical insurance policy inquiries, reduce labor costs, and improve user experience [1] Group 2 - Cloud Wisdom Technology Co., Ltd. (Cloud Wisdom) successfully won the bid for the medical insurance knowledge intelligent Q&A system project from China P&C, with a bid amount of 2.714 million yuan [2] - This collaboration marks a significant breakthrough for Cloud Wisdom in the application of artificial intelligence within the insurance industry, providing core support for the intelligentization of medical insurance services at China P&C [2] - Cloud Wisdom's strong capabilities in natural language processing and knowledge graph technology were recognized by evaluation experts, leading to its top position in the list of winning candidates [1][2]

Core Viewpoint - The announcement details the appointment of Ms. Yang Changying as an independent director of China People's Insurance Group Co., Ltd., effective from February 2, 2026, following approval from the National Financial Regulatory Administration [2][5]. Group 1 - The company held its first extraordinary general meeting of shareholders on April 29, 2025, where Ms. Yang was elected as an independent director [1]. - Ms. Yang's term as an independent director will commence upon the approval of her qualifications by the National Financial Regulatory Administration [1]. - Ms. Yang will also serve on the Board's Strategy and Investment/Sustainability Committee, Nomination and Remuneration Committee, and Related Party Transaction Control Committee starting from the same date [2]. Group 2 - The company welcomes Ms. Yang to the Board [3]. - Ms. Yang has made a declaration affirming her independence and commitment to fulfilling her responsibilities as an independent director [5]. - She has pledged to dedicate sufficient time and effort to uphold the rights of the insurance company, policyholders, and minority shareholders [5].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 （於中華人民共和國註冊成立之股份有限公司） （股份代號：1339) 董事名單與其角色和職能 三、獨立非執行董事 一、執行董事 丁向群 （董事長） 趙 鵬 （副董事長） 肖建友 二、非執行董事 徐 向 王少群 喻 強 宋洪軍 M： 有關專業委員會的委員 中國北京，2026年2月4日 2 董事會下設五個董事會專業委員會，各董事會專業委員會的組成如下： 委員會 董事 戰略與投資╱ 可持續發展 委員會 風險管理與 消費者權益 保護委員會 審計 委員會 提名薪酬 委員會 關聯交易 控制委員會 丁向群 C 趙 鵬 C 肖建友 M 徐 向 M M 王少群 M M 喻 強 M M 宋洪軍 M M 徐麗娜 M M M 王鵬程 C M M 高平陽 M M C 賈 若 M M C 楊長纓 M M M 徐麗娜 王鵬程 高平陽 賈 若 楊長纓 1 四、董事會專業委員會 C： 有關專業委員會的主任委員 ...

致：香港交易及結算所有限公司 公司名稱: 中國人民保險集團股份有限公司 呈交日期: 2026年2月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01339 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 8,726,234,000 | RMB | | 1 RMB | | 8,726,234,000 | | 增加 / 減少 (-) | | | 0 | | | RMB | | 0 | | 本月底結存 | | | 8,726,234,000 | RMB | | 1 RMB | | 8,726,234,000 | 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 | 2. 股份分類 | 普通股 | 股份類別 ...

会会议资料》。 本公司欢迎杨长缨女士加入董事会。 特此公告。 中国人民保险集团股份有限公司董事会 2026 年 2 月 4 日 证券代码：601319 证券简称：中国人保 公告编号：临 2026-001 中国人民保险集团股份有限公司 关于独立董事任职的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 中国人民保险集团股份有限公司（以下简称"本公司"）于 2025 年 4 月 29 日召开 2025 年第一次临时股东大会，选举杨长缨女士为本 公司第五届董事会独立董事。杨长缨女士担任本公司独立董事的任 期，自股东大会审议通过其担任本公司独立董事且其独立董事任职资 格获得国家金融监督管理总局核准之日起算。 近日，本公司收到《国家金融监督管理总局关于杨长缨中国人民 保险集团股份有限公司独立董事任职资格的批复》（金复〔2026〕64 号）。根据上述批复，国家金融监督管理总局已核准杨长缨女士担任 本公司独立董事的任职资格。杨女士担任本公司独立董事的任职自 2026 年 2 月 2 日起生效，且根据本公司 2025 年 6 月 27 ...

Core Viewpoint - China People's Insurance Company (601319.SH) announced the election of Ms. Yang Changying as an independent director at the first extraordinary shareholders' meeting scheduled for April 29, 2025 [1] Group 1: Appointment Details - Ms. Yang Changying's term as an independent director will commence from the date the shareholders' meeting approves her appointment and her qualifications are approved by the National Financial Regulatory Administration [1] - The National Financial Regulatory Administration has granted approval for Ms. Yang's qualifications as an independent director, effective from February 2, 2026 [1] Group 2: Committee Membership - Following the resolution of the tenth meeting of the fifth board of directors on June 27, 2025, Ms. Yang will also serve as a member of the Strategic and Investment/Sustainable Development Committee, the Nomination and Remuneration Committee, and the Related Party Transaction Control Committee [1]

Core Viewpoint - China People's Insurance Company (601319.SH) announced the election of Ms. Yang Changying as an independent director at the first extraordinary general meeting of shareholders scheduled for April 29, 2025 [1] Group 1: Appointment Details - Ms. Yang Changying's term as an independent director will commence from the date of approval by the National Financial Regulatory Administration, following the shareholders' meeting [1] - The company received approval from the National Financial Regulatory Administration regarding Ms. Yang's qualifications to serve as an independent director [1] - Ms. Yang's appointment as an independent director will be effective from February 2, 2026 [1] Group 2: Committee Membership - Following the resolution of the tenth meeting of the fifth board of directors on June 27, 2025, Ms. Yang will also serve on the Strategy and Investment/Sustainable Development Committee, the Nomination and Compensation Committee, and the Related Party Transaction Control Committee [1]

Group 1 - The core point of the article is the appointment of Ms. Yang Changying as an independent non-executive director of China People's Insurance Group, which has been approved by the National Financial Regulatory Administration [2] - The appointment will take effect on February 2, 2026 [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 （於中華人民共和國註冊成立之股份有限公司） （股份代號：1339) 董事名單與其角色和職能 一、執行董事 丁向群 （董事長） 趙 鵬 （副董事長） 肖建友 二、非執行董事 徐 向 王少群 喻 強 宋洪軍 三、獨立非執行董事 徐麗娜 王鵬程 高平陽 賈 若 楊長纓 1 四、董事會專業委員會 C： 有關專業委員會的主任委員 M： 有關專業委員會的委員 中國北京，2026年2月4日 2 董事會下設五個董事會專業委員會，各董事會專業委員會的組成如下： 委員會 董事 戰略與投資╱ 可持續發展 委員會 風險管理與 消費者權益 保護委員會 審計 委員會 提名薪酬 委員會 關聯交易 控制委員會 丁向群 C 趙 鵬 C 肖建友 M 徐 向 M M 王少群 M M 喻 強 M M 宋洪軍 M M 徐麗娜 M M M 王鵬程 C M M 高平陽 M M C 賈 若 M M C 楊長纓 M M M ...